ENLIVEN THERAPEUTICS ANNOUNCES POSITIVE DATA UPDATE FROM PHASE 1 CLINICAL TRIAL OF ELVN-001 IN CHRONIC MYELOID LEUKEMIA

Reuters · 09/28 13:35
ENLIVEN THERAPEUTICS ANNOUNCES POSITIVE DATA UPDATE FROM PHASE 1 CLINICAL TRIAL OF ELVN-001 IN CHRONIC MYELOID LEUKEMIA